ASRS: Medicare Survey Analysis Of Patients With Neovascular Age-Related Macular Degeneration
Only a third of Medicare beneficiaries were persistent with anti-VEGF monotherapy each year. Overall, two-thirds of patients treated with anti-VEGF at baseline (BL) reported similar or better visual function after 2 years....
Read More